How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS-Reference-Cited by-同舟云学术

How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS

Published:2012-09-24 Issue:9-10 Volume:6 Page:437-442
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Mischak Harald¹²

Affiliation:

1. BHF Glasgow Cardiovascular Research Centre; Institute of Cardiovascular and Medical Sciences; College of Medical; Veterinary and Life Sciences; University of Glasgow; Glasgow UK

2. Mosaiques Diagnostics; Hannover Germany

Funder

EuroKUP COST Action

FP7-PEOPLE-2009-IAPP

European Community's 7th Framework Programme

MRC

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201200027/fullpdf

Reference43 articles.

1. Common sense approaches to urinary biomarker study design;Knepper;J. Am. Soc. Nephrol.,2009

2. Recommendations for biomarker identification and qualification in clinical proteomics;Mischak;Sci. Transl. Med.,2010

3. Clinical Proteomics: a need to define the field and to begin to set adequate standards;Mischak;Proteomics Clin. Appl.,2007

4. Pathways to translation of proteomics into clinical practice;Patterson;Proteomics Clin Appl.,2010

5. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses;Ioannidis;JAMA,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass spectrometry-based proteomics as an emerging tool in clinical laboratories;Clinical Proteomics;2023-08-26

2. Peptides as “better biomarkers”? Value, challenges, and potential solutions to facilitate implementation;Mass Spectrometry Reviews;2023-06-26

3. Peptidomics and proteomics based on CE‐MS as a robust tool in clinical application: The past, the present, and the future;ELECTROPHORESIS;2019-05-14

4. Recent insights intoMycobacterium tuberculosisthrough proteomics and implications for the clinic;Expert Review of Proteomics;2019-04-27

5. Urinary peptidomics in kidney disease and drug research;Expert Opinion on Drug Discovery;2017-12-19